2016 Annual Meeting: Best of ASCO Washington, DC
July 15-16, 2016 | Washington, D.C. USA
The Best of ASCO Meetings condense the most cutting-edge science and education from the world’s premier oncology event, the ASCO Annual Meeting, into a two-day program. The abstracts chosen for presentation and discussion reflect the foremost research and strategies in oncology that will directly impact patient care. The program features in-depth discussion and analysis on the latest scientific findings in primary disease sites and practice-changing advances in cancer treatment. Expert faculty will place abstract findings into clinical context and discuss how the results may change the current standard of care.
The 43rd International Society of Oncology and Biomarkers (ISOBM) Annual Congress
September 1-6, 2016 | Chicago, Illinois USA
With the theme “Towards Precision Medicine: From Biomarker Discovery to Novel Therapies,” the Congress links all fields of cancer research and oncology. The 2016 theme of the ISOBM Congress is to translate new findings into clinical practice, and to invite interdisciplinary and innovative approaches. The latest findings in cancer research, diagnosis and clinical oncology will be presented in oral and poster format, along with panel discussions and special topic seminars. The conference seeks to engage professionals in the field of cancer research, oncology, and biomarkers in collaboration and exchange ideas and expertise on a global platform.
11th Biennial Ovarian Cancer Research Symposium
September 12-13, 2016 | Seattle, Washington USA
The 11th Biennial Ovarian Cancer Research Symposium is presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research. The goal of the Symposium is to bring together clinicians and researchers from across many disciplines and institutions worldwide in order to encourage collaborations toward advancing the field of ovarian cancer research. The conference seeks to enhance the understanding and knowledge of ovarian cancer, especially among junior investigators, discuss the most recent innovations in the field of ovarian cancer research, and address pressing concerns of the leaders in the clinical and research community. This year’s Symposium will focus on the following topics: “detection & prevention of ovarian cancer,” “mechanisms of initiation & progression of ovarian cancer,” “tumor microenvironment & models of ovarian cancer,” and “novel therapeutics for ovarian cancer”.
2016 ASH Meeting on Hematologic Malignancies
September 16-17, 2016 | Chicago, Illinois USA
Contact: (202) 776-0544
World-class experts in hematologic malignancies will discuss their personal evidence-based treatment approaches and the latest developments in clinical care at the 2016 ASH Meeting on Hematologic Malignancies. The majority of the program content will be structured as “How I Treat” sessions on core malignancies, including leukemia, lymphoma, myelodysplastic syndromes, myeloma, and myeloproliferative neoplasms. Each presentation will showcase the speaker’s evidence-based treatment approaches, ranging from standard of care, specialized disease complications, and novel agent discussions. The meeting will also feature topic-based panel discussions which will allow participants to get answers to their most challenging patient care questions.
The 6th New York Health Forum
September 27, 2016 | New York, New York USA
The New York Health Forum’s mission is to present the significant agendas for the healthcare industry, contribute to public health by bringing out the public concerns to be discussed and solved, and gather the sound of health policy, science innovation and industry development. A major goal of the NYHF is to create the foundation of communication among all areas of the healthcare industry resulting in solution, which combines the ideas of science, industry, and policy for a healthier society.
National Comprehensive Cancer Network (NCCN) 11th Annual Congress: Hematologic Malignancies
September 30, October 1, 2016 | New York, New York USA
Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients. This congress focuses on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics.
7th Annual World Antibody-Drug Conjugates (ADC)
October 10-13, 2016 | San Diego, California USA
World ADC San Diego is the definitive forum for sharing new antibody drug conjugate insights and data. Specifically focussed on ADCs and crafted with the field’s thought-leaders, World ADC is the industry’s definitive forum for learning and networking. Across 4 streams and 96 sessions, World ADC will cover every element of drug development from discovery to preclinical, clinical and manufacturing offering you an unparalleled breadth and depth of cutting-edge knowledge. You will learn from 90 ADC experts at the likes of Stemcentrx, Seattle Genetics and Genentech as they share their latest intelligence on how to: design ADCs which have superior efficacy and safety profiles, improve the preclinical predictability of your ADC to effectively translate into the clinic, expand the clinical therapeutic window of your ADC, and advance your ADC drug manufacturing to robustly scale up from phase 1 to phase 3.
The 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow
November 9-11, 2016 | New York, New York USA
The annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® (CFS) has brought together over 2,000 oncologists, hematologists, radiation oncologists, immunologists, oncology nurses, nurse practitioners, physician assistants, and case managers each year for 33 years, with the aim of educating these disciplines on state-of-the-art treatments across solid and hematologic malignancies and diverse clinical scenarios. At the 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® (CFS), leading clinical innovators in virtually every tumor subspecialty will provide expert insights on new developments in cancer therapeutics, and provide oncology professionals with the opportunity to learn about new compounds, novel approaches to diagnosis and treatment with currently available agents, ongoing clinical trials, and emerging developments that define current progress aimed at the goal of control and cure of cancer.
The 58th American Society of Hematology (ASH) Annual Meeting & Exposition
December 3-6, 2016 | San Diego, California USA
The ASH Annual Meeting provides an invaluable educational experience and an opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology. Participants will be able to network with top minds in the field, as well as a global community of more than 20,000 hematology professionals from every subspecialty.
The 16th International Conference on Progress in Vaccination Against Cancer (PIVAC-16)
September 12-14, 2016 | Winchester, United Kingdom
Progress in Vaccination Against Cancer (PIVAC) aims to bring together translational and clinical oncologists and immunologists dealing with active vaccination against cancer for three days of presentations on the most recent advances in the field. The meeting provides an up-to-date overview of many aspects of tumour immunology. Thanks to its friendly atmosphere and the limited number (max 100) of participants, PIVAC cultivates lively and fruitful discussions, promotes interactions between participants, speakers and companies attending the conference and encourages the emergence of new partnerships.
Translational Vaccinology for Global Health
October 26-30, 2016 | London, United Kingdom
This conference aims to bring together those pioneering novel, creative solutions to problems of global vaccine discovery and development across the academic/biotech/product development partner/pharma spectrum.
EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium
November 29-December 2, 2016 | Munich, Germany
Hosted by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), the 2016 Symposium will bring together around 2000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology. As a one-of-a-kind Symposium at the forefront of drug development, it will enable participants to apply the latest findings and knowledge in their work and practice.
International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer
December 4-7, 2016 | Vienna, Austria
The IASLC World Conference on Lung Cancer (WCLC) is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. More than 7,000 delegates come from more than 100 countries to discuss the latest developments in thoracic malignancy research. Attendees include surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, nurses and allied health professionals and patients.
The 33rd World Congress of Internal Medicine
August 22-25, 2016 | Bali, Indonesia
The International Society of Internal Medicine (ISIM) was founded in 1948 in Basel, Switzerland. Its purpose is to promote scientific knowledge and unity in Internal Medicine, to further the education of young internists and to encourage friendship between physicians in all over the world. The 33rd World Congress of Internal Medicine will discuss important subjects such as medical, internal medicine, chemical biology and health care. The ISIM holds the congress biennially.
ISPOR 7th Asia-Pacific Conference
September 3-6, 2016 | Suntec City, Singapore
The ISPOR Asia-Pacific Congress features 3 thought-provoking plenary sessions and more than 600 presentations in the form of workshops, issue panels and podium presentations plus posters on innovative research methods, health policy development using outcomes research, patient preferences, real world data, clinical, economic, and patient-reported outcomes.
International Continence Society 46th Annual Meeting (ICS 2016)
September 13-16, 2016 | Tokyo, Japan
The meeting is an international event on continence medicine and care. It is unique in bringing together multidisciplinary professionals including urologists, gynaecologists, neurologists, physiotherapists, nurses, physiologists and scientists. The topics discussed will be issues on pathophysiology, diagnosis and management of incontinence. The scope of the meeting will widely range from basic laboratory/animal experiments to surgical; physical and medical treatments to psychosocial aspects of elimination problems.
The 9th Asia Pacific Heart Rhythm Society Scientific Session
October 12-15, 2016 | Seoul, Republic of Korea
APHRS 2016 will bring together over 3,000 attendees including professionals and experts from the Asia Pacific region to keep up-todate on the latest clinical trials and studies in the sphere of arrhythmia, share their experience, ideas and strategies, and to discuss the current issues facing those involved in this field.